Research Article

[Retracted] Targeting AraC-Resistant Acute Myeloid Leukemia by Dual Inhibition of CDK9 and Bcl-2: A Systematic Review and Meta-Analysis

Scheme 1

Chemical structure of AZD4573. AZD4573 is a novel and selective inhibitor of CDK9, exhibiting rapid cell-death induction in most hematologic blood cancer cell lines.